FKB238

· Centus Biotherapeutics Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FKB238, covering 2020-03-19 to 2020-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer [Phase 3]

See pricing